Skip to main content
. 2024 Mar 1;27(3):122–126. doi: 10.34172/aim.2024.19

Table 1. Clinical Characteristics of Study Patients .

Parameters Number (%) of Patients
Total number of patients 52
Gender
Male 36 (69.2)
Female 16 (30.8)
Age
0‒20 years 1 (1.9)
21‒40 years 21 (40.3)
41‒60 years 18 (34.6)
 > 60 years 12 (23)
Status of the viral infection
HBV 1 (1.9)
HCV 13 (25)
HIV 23 (44.2)
History of smoking 33 (63.5)
History of alcohol consumption 8 (15.4)
History of drug abuse 29 (55.8)
Co-morbidity
Cardiovascular diseases 8 (25)
Renal diseases 5 (15.6)
Pulmonary diseases 11 (34.3)
Rheumatologic diseases 3 (9.3)
Malignancies 5 (15.6)
Type of liver injury
Hepatocellular 37 (71.2)
Cholestatic 3 (5.8)
Mixed hepatocellular- cholestatic 12 (23.1)
Clinical manifestations of hepatotoxicity
Nausea/vomiting 8 (15.3)
Nausea/vomiting + abdominal pain 14 (26.9)
Jaundice 13 (25)
Asymptomatic 17 (32.6)

Note. HBV: Hepatitis B virus; HCV: Hepatitis C virus; HIV: Human immunodeficiency virus.